Jefferies and Piper Sandler are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP:
- Corbus Pharmaceuticals Announces Preliminary Q3 Financials
- Corbus announces common stock and warrants offering, no amount given
- Corbus Pharmaceuticals price target raised to $39 from $32 at Mizuho
- Corbus Pharmaceuticals Advances CRB-701 Clinical Study for Solid Tumors
- Corbus Pharmaceuticals’ CRB-601 Study: A New Hope for Advanced Solid Tumors